波士顿科学Boston Scientific Corporation (BSX) 2002年年度报告「NYSE」.pdf

1、2002 ANNUAL REPORTDELIVERING WHATS NEXTKEITH D.DAWKINS,M.D.,PRINCIPAL INVESTIGATOR,TAXUS VI CLINICAL TRIAL.DELIVERING WHATS NEXT.Boston Scientific is focused.Focused on developing innovative technologiesto help clinicians improve the quality of their patients lives.Focused onachieving unprecedented

2、milestones.Focused on advancing the quality anddelivery of less-invasive medicine.Focused on continued long-term growth.Today we find ourselves at a pivotal point in our Companys history,whenbreakthrough technologies are altering the competitive landscape.We standat the beginning of a new era in our

3、 history,preparing for the opportunityto dramatically grow and expand our business.It is appropriate that at this time we complete the evolution of our corporateidentity and present ourselves as one company unified under one brand.Forus,this means being known simply as Boston Scientific and no longe

4、r usingdivisional names.Our new master brand is built on our talented employees,the breadth and depth of our technologies,collaborative relationships withour customers,and our sustained leadership in the medical device industry.As part of our new master brand,we are proud to introduce a tagline that

5、positions our Company as an organization committed to further advancingmedical technology:Delivering whats next.This tagline is intended toconvey the essence of Boston Scientific:a committed,forward-lookingcompany dedicated to executing on our promises and bringing the latestmedical innovations to o

6、ur customers and their patients.MISSIONBOSTON SCIENTIFICS MISSION IS TO IMPROVE THE QUALITY OF PATIENT CARE AND THE PRODUCTIVITYOF HEALTH CARE DELIVERY THROUGH THE DEVELOPMENT AND ADVOCACY OF LESS-INVASIVE MEDICALDEVICES AND PROCEDURES.THIS IS ACCOMPLISHED THROUGH THE CONTINUING REFINEMENT OF EXISTI